Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Though you can hit speed bumps in your weight loss journey, Hone Health says there are minor tweaks you can make to get your ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

(Reuters) - Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales of popular weight-loss drug Zepbound after it last month ...

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter despite missing the company’s initial sales expectations. Zepbound sales reached $1.9 billion in ...

Zepbound is a subcutaneous injection that needs ... If needed, you can adjust your weekly dose schedule to fit your travel plans, but make sure there are at least 3 days (72 hours) between doses.

As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...

Jonathan Wolf, the CEO of the nutrition company ZOE, gradually changed his diet to care for his gut health and cut down on ...